Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Moore

Showing results (231-240 of 500) with videos related to

Pageof 50
Sort By:
AIDS (London, England)|August 1, 2024
The anxiety care continuum and its association with viral suppression among persons with HIVLauren C Zalla, Heidi E Hutton, Anthony T Fojo, et al.
The Journal of Infectious Diseases|February 15, 2007
Stability of the latent reservoir for HIV-1 in patients receiving valproic acidJanet D Siliciano, Jun Lai, Marc Callender, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 8, 2018
Cocaine use may induce telomere shortening in individuals with HIV infectionShenghan Lai, Christopher M Heaphy, Anthony J Rizzo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 12, 2008
Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapyFred Lutwama, Ronnie Serwadda, Harriet Mayanja-Kizza, et al.
Journal of Clinical Microbiology|October 5, 2012
Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimationSheila M Keating, Debra Hanson, Mila Lebedeva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2025
Clinical predictors and incidence of Kaposi sarcoma among males with HIV in the Treat-all era in the United States and CanadaSally B Coburn, Michael J Silverberg, Raynell Lang, et al.
Medical Care|October 26, 2006
The lifetime cost of current human immunodeficiency virus care in the United StatesBruce R Schackman, Kelly A Gebo, Rochelle P Walensky, et al.
BMC Infectious Diseases|December 20, 2014
Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, BrazilSandra W Cardoso, Paula M Luz, Luciane Velasque, et al.
The Journal of Infectious Diseases|October 4, 2023
Hepatitis C Treatment in People With HIV: Potential to Eliminate Disease and DisparityOluwaseun Falade-Nwulia, Catherine R Lesko, Anthony T Fojo, et al.
AIDS Research and Human Retroviruses|August 3, 2010
Incidence of modifying or discontinuing first HAART regimen and its determinants in a cohort of HIV-infected patients from Rio de Janeiro, BrazilSandra W Cardoso, Beatriz Grinsztejn, Luciane Velasque, et al.
Pageof 50

Showing results (231-240 of 500) with videos related to

Sort By:
Pageof 50
AIDS (London, England)|August 1, 2024
The anxiety care continuum and its association with viral suppression among persons with HIVLauren C Zalla, Heidi E Hutton, Anthony T Fojo, et al.
The Journal of Infectious Diseases|February 15, 2007
Stability of the latent reservoir for HIV-1 in patients receiving valproic acidJanet D Siliciano, Jun Lai, Marc Callender, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 8, 2018
Cocaine use may induce telomere shortening in individuals with HIV infectionShenghan Lai, Christopher M Heaphy, Anthony J Rizzo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 12, 2008
Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapyFred Lutwama, Ronnie Serwadda, Harriet Mayanja-Kizza, et al.
Journal of Clinical Microbiology|October 5, 2012
Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimationSheila M Keating, Debra Hanson, Mila Lebedeva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2025
Clinical predictors and incidence of Kaposi sarcoma among males with HIV in the Treat-all era in the United States and CanadaSally B Coburn, Michael J Silverberg, Raynell Lang, et al.
Medical Care|October 26, 2006
The lifetime cost of current human immunodeficiency virus care in the United StatesBruce R Schackman, Kelly A Gebo, Rochelle P Walensky, et al.
BMC Infectious Diseases|December 20, 2014
Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, BrazilSandra W Cardoso, Paula M Luz, Luciane Velasque, et al.
The Journal of Infectious Diseases|October 4, 2023
Hepatitis C Treatment in People With HIV: Potential to Eliminate Disease and DisparityOluwaseun Falade-Nwulia, Catherine R Lesko, Anthony T Fojo, et al.
AIDS Research and Human Retroviruses|August 3, 2010
Incidence of modifying or discontinuing first HAART regimen and its determinants in a cohort of HIV-infected patients from Rio de Janeiro, BrazilSandra W Cardoso, Beatriz Grinsztejn, Luciane Velasque, et al.
Pageof 50